248 related articles for article (PubMed ID: 31150789)
1. Efficacy and Safety of Sesame Oral Immunotherapy-A Real-World, Single-Center Study.
Nachshon L; Goldberg MR; Levy MB; Appel MY; Epstein-Rigbi N; Lidholm J; Holmqvist M; Katz Y; Elizur A
J Allergy Clin Immunol Pract; 2019; 7(8):2775-2781.e2. PubMed ID: 31150789
[TBL] [Abstract][Full Text] [Related]
2. Patient Characteristics and Risk Factors for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy.
Nachshon L; Schwartz N; Tsviban L; Levy MB; Goldberg MR; Epstein-Rigby N; Katz Y; Elizur A
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):185-192.e3. PubMed ID: 32750430
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of patients diagnosed as non-allergic following food allergy oral immunotherapy referral.
Koren Y; Nachshon L; Goldberg MR; Levy MB; Epstein-Rigbi N; Elizur A
Pediatr Res; 2023 Feb; 93(3):643-648. PubMed ID: 35641552
[TBL] [Abstract][Full Text] [Related]
4. Severe Anaphylactic Reactions to Home Doses of Oral Immunotherapy for Food Allergy.
Nachshon L; Schwartz N; Levy MB; Goldberg M; Epstein-Rigbi N; Katz Y; Elizur A
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2524-2533.e3. PubMed ID: 36925102
[TBL] [Abstract][Full Text] [Related]
5. Oral Immunotherapy for Hazelnut Allergy: A Single-Center Retrospective Study on 100 Patients.
Moraly T; Pelletier de Chambure D; Verdun S; Preda C; Seynave M; Vilain AC; Chenivesse C; Delebarre-Sauvage C
J Allergy Clin Immunol Pract; 2020 Feb; 8(2):704-709.e4. PubMed ID: 31751759
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of food allergy oral immunotherapy in adults.
Epstein-Rigbi N; Levy MB; Nachshon L; Koren Y; Katz Y; Goldberg MR; Elizur A
Allergy; 2023 Mar; 78(3):803-811. PubMed ID: 36190349
[TBL] [Abstract][Full Text] [Related]
7. Cashew oral immunotherapy for desensitizing cashew-pistachio allergy (NUT CRACKER study).
Elizur A; Appel MY; Nachshon L; Levy MB; Epstein-Rigbi N; Koren Y; Holmqvist M; Porsch H; Lidholm J; Goldberg MR
Allergy; 2022 Jun; 77(6):1863-1872. PubMed ID: 35000223
[TBL] [Abstract][Full Text] [Related]
8. Measurement of specific IgE antibodies to Ses i 1 improves the diagnosis of sesame allergy.
Maruyama N; Nakagawa T; Ito K; Cabanos C; Borres MP; Movérare R; Tanaka A; Sato S; Ebisawa M
Clin Exp Allergy; 2016 Jan; 46(1):163-71. PubMed ID: 26310924
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with home epinephrine-treated reactions during peanut and tree-nut oral immunotherapy.
Nachshon L; Schwartz N; Levy MB; Goldberg MR; Epstein-Rigbi N; Katz Y; Elizur A
Ann Allergy Asthma Immunol; 2023 Mar; 130(3):340-346.e5. PubMed ID: 36509409
[TBL] [Abstract][Full Text] [Related]
10. Multicenter, randomized, double-blind, placebo-controlled clinical trial of vital wheat gluten oral immunotherapy.
Nowak-Węgrzyn A; Wood RA; Nadeau KC; Pongracic JA; Henning AK; Lindblad RW; Beyer K; Sampson HA
J Allergy Clin Immunol; 2019 Feb; 143(2):651-661.e9. PubMed ID: 30389226
[TBL] [Abstract][Full Text] [Related]
11. The Effectiveness of Oral Immunotherapy in Patients with Sesame Anaphylaxis using Omalizumab.
Salari F; Bemanian MH; Fallahpour M; Mahdaviani SA; Shokri S; Khoshmirsafa M; Seif F; Nabavi M; Arshi S
Clin Med Res; 2022 Aug; 20(3):125-32. PubMed ID: 35998948
[TBL] [Abstract][Full Text] [Related]
12. Safety of Multifood Oral Immunotherapy in Children Aged 1 to 18 Years at an Academic Pediatric Clinic.
Nguyen K; Lewis MO; Hanna E; Alfaro MKC; Corrigan K; Buonanno J; Datta R; Brown-Whitehorn T; Spergel JM; Cianferoni A
J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1907-1913.e1. PubMed ID: 36907355
[TBL] [Abstract][Full Text] [Related]
13. Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.
Scurlock AM
Clin Rev Allergy Immunol; 2018 Oct; 55(2):139-152. PubMed ID: 29656306
[TBL] [Abstract][Full Text] [Related]
14. Sesame eliciting and safe doses in a large sesame allergic population.
Nachshon L; Westerhout J; Blom WM; Remington B; Levy MB; Goldberg MR; Epstein-Rigbi N; Katz Y; Elizur A
Allergy; 2023 Dec; 78(12):3212-3220. PubMed ID: 37606275
[TBL] [Abstract][Full Text] [Related]
15. Oral immunotherapy for multiple foods in a pediatric allergy clinic setting.
Eapen AA; Lavery WJ; Siddiqui JS; Lierl MB
Ann Allergy Asthma Immunol; 2019 Dec; 123(6):573-581.e3. PubMed ID: 31494236
[TBL] [Abstract][Full Text] [Related]
16. Quality of Life of Food-Allergic Patients Before, During, and After Oral Immunotherapy.
Epstein-Rigbi N; Goldberg MR; Levy MB; Nachshon L; Elizur A
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):429-436.e2. PubMed ID: 30129441
[TBL] [Abstract][Full Text] [Related]
17. Safety and Effectiveness of Bypassing Oral Immunotherapy Buildup With an Initial Phase of Sublingual Immunotherapy for Higher-Risk Food Allergy.
Soller L; Williams BA; Mak R; Wong T; Erdle SC; Chomyn A; Tetreault B; Morrison K; Gaudet L; Chan ES
J Allergy Clin Immunol Pract; 2024 May; 12(5):1283-1296.e2. PubMed ID: 38423293
[TBL] [Abstract][Full Text] [Related]
18. First Real-World Safety Analysis of Preschool Peanut Oral Immunotherapy.
Soller L; Abrams EM; Carr S; Kapur S; Rex GA; Leo S; Lidman PG; Yeung J; Vander Leek TK; McHenry M; Wong T; Cook VE; Hildebrand KJ; Gerstner TV; Mak R; Lee NJ; Cameron SB; Chan ES
J Allergy Clin Immunol Pract; 2019; 7(8):2759-2767.e5. PubMed ID: 31002957
[TBL] [Abstract][Full Text] [Related]
19. Triggers for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy.
Nachshon L; Levy MB; Goldberg MR; Epstein-Rigbi N; Schwartz N; Katz Y; Elizur A
J Allergy Clin Immunol Pract; 2022 Apr; 10(4):1070-1076.e2. PubMed ID: 34982978
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for Food Allergy: Are We There Yet?
Gernez Y; Nowak-Węgrzyn A
J Allergy Clin Immunol Pract; 2017; 5(2):250-272. PubMed ID: 28283151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
